Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-28T05:19:04.759Z Has data issue: false hasContentIssue false

Chapter 3 - Illicit Drug Use: Clinical Features and Treatment

Published online by Cambridge University Press:  02 November 2021

By
Ed Day
Edited by
Ed Day
Get access

Summary

This chapter starts by describing the key features of drug use disorders and how to assess them, including using objective tests of substance use. The principles of medical treatment are described, incorporating harm reduction strategies, medically assisted withdrawal, agonist therapies and relapse prevention. Opiates are used as a case study to consider the theory and practicalities of each approach, before describing how to integrate psychosocial interventions into an integrated approach to treatment. Stimulants and cannabis are then considered, before a review of the overarching concept of recovery and its application in recovery-orientated systems of care.

Keywords

illicit drugsassessmenturine testingharm reductionmedically assisted withdrawalopioid agonist therapyrelapse preventionpsychosocial interventionrecoveryrecovery orientated systems of care
Type
Chapter
Information
Seminars in Addiction Psychiatry , pp. 42 - 67
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Independent Expert Working Group. Clinical Guidelines on Drug Misuse and Dependence Update, 2017. Drug Misuse and Dependence: UK Guidelines on Clinical Management. Department of Health, 2017.Google Scholar
Day, E. Building bridges to positive social identities: the social network diagram and opiate substitution treatment. In: Addiction, Behavioural Change and Social Identity (eds. Buckingham, S. A., Best, D.). Routledge, 2017.Google Scholar
O’Brien, C. P., McLellan, A. T. Myths about the treatment of addiction. The Lancet. 1996; 347: 237–40.Google ScholarPubMed
Advisory Council on the Misuse of Drugs. AIDS and Drug Misuse: Part 1. HMSO, 1988.Google Scholar
Strang, J., McDonald, R. Preventing Opioid Overdose Deaths With Take-Home Naloxone. European Monitoring Centre for Drugs and Drug Addiction, 2016.Google Scholar
National Collaborating Centre for Mental Health. Opiate Detoxification for Drug Misuse, 2007.Google Scholar
Strang, J., McCambridge, J., Best, D., Beswick, T., Bearn, J., Rees, S. et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ. 2003; 326 (7396): 959–60.CrossRefGoogle ScholarPubMed
Green, L., Gossop, M. Effects of information on the opiate withdrawal syndrome. British Journal of Addiction. 1988; 83: 305–9.Google Scholar
National Treatment Agency for Substance Misuse. Drug Misuse: Opioid Detoxification. NICE, 2007.Google Scholar
Nosyk, B., Sun, H., Evans, E., Marsh, D. C., Anglin, M. D., Hser, Y.-I. et al. Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study. Addiction. 2012; 107 (9): 1621–9.CrossRefGoogle ScholarPubMed
Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Fry-Smith, A. et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technology Assessment. 2006; 11 (9): 1–171.Google Scholar
Simpson, D., Sells, S. B. Opioid Addiction and Treatment: A 12-Year Follow-Up. Malabar, FL: Robert E. Krieger Publishing Co., 1990.Google Scholar
Krantz, M. J., Martin, J., Stimmel, B., Mehta, D., Haigney, M. C. P. QTc interval screening in methadone treatment. Annals of Internal Medicine. 2009; 150 (6): 387–95.Google Scholar
Recovery Orientated Drug Treatment Expert Group. Medications in Recovery: Re-Orientating Drug Dependence Treatment. National Treatment Agency, 2012.Google Scholar
Dole, V. P., Nyswander, M. E. Heroin addiction – a metabolic disease. Archives of Internal Medicine. 1967; 120 (1): 19–24.Google Scholar
White, W., Mojer-Torres, L. Recovery-Oriented Methadone Maintenance. Northeast Addiction Technology Transfer Center, 2010.Google Scholar
Simpson, D. D. A conceptual framework for drug treatment process and outcomes. Journal of Substance Abuse Treatment. 2004; 27: 99–121.Google Scholar
Prochaska, J. O., DiClemente, C. C. Transtheoretical therapy: Toward a more integrative model of change. Psychotherapy Theory Research and Practice. 1982; 19 (3): 276–88.Google Scholar
Moos, R. H. Theory-based active ingredients of effective treatments for substance use disorders. Drug and Alcohol Dependence. 2007; 88 (2–3): 109–21.Google Scholar
Petry, N. M. Contingency management treatments. British Journal of Psychiatry. 2006; 189: 97–8.Google Scholar
Meyers, R. J., Miller, W. R. A Community Reinforcement Approach to Addiction Treatment. Cambridge: Cambridge University Press, 2001.CrossRefGoogle Scholar
Day, E. Routes to Recovery via the Community. Public Health England, 2013.Google Scholar
Substance Abuse and Mental Health Services Administration: Centre for Substance Abuse Treatment. Treatment for stimulant use disorders. In: Treatment Improvement Protocol (TIP) Series. US Department of Health and Human Services, 1999.Google Scholar
White, W. L. Pathways from the Culture of Addiction to the Culture of Recovery. Center City, MN: Hazelden, 1996.Google Scholar
US Department of Health and Human Services (HHS): Office of the Surgeon General. Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. HHS, 2016.Google Scholar
UK Drug Policy Commission Recovery Consensus Group. A Vision of Recovery. UK Drug Policy Commission, 2008.Google Scholar
Ashton, M. The new abstentionists. Druglink. 2007; Special Insert (Dec/Jan 2008): 1–16.Google Scholar
Ashford, R. D., Brown, A. M., Ryding, R., Curtis, B. Building recovery ready communities: The recovery ready ecosystem model and community framework. Addiction Research and Theory. 2020; 28 (1): 1–11.CrossRefGoogle Scholar
Achara-Abrahams, I., Evans, A. C., King, J. K. Recovery-focused behavioral health system transformation: A framework for change and lessons learned from Philadelphia. In: Addiction Recovery Management: Theory, Research and Practice (eds. Kelly, J. F., White, W. L.): 187–208. New York: Humana Press, 2011.Google Scholar
Kirk, T. A. Connecticut’s journey to a statewide recovery-oriented health-care system: Strategies, successes, and challenges. In: Addiction Recovery Management: Theory, Research and Practice (eds. Kelly, J. F., White, W. L.): 209–34. New York: Humana Press, 2011.Google Scholar
Davidson, L., White, W. The concept of recovery as an organizing principle for integrating mental health and addiction services. Journal of Behavorial Health Services and Research. 2007; 34 (2): 109–20.Google Scholar
National Institute on Drug Abuse. Principles of Drug Addiction Treatment: A Research-Based Guide. NIDA, 2018. [Available from: https://bit.ly/39twZYf.]Google Scholar
Simoneau, H., Kamgang, E., Tremblay, J., Bertrand, K., Brochu, S., Fleury, M.-J. Efficacy of extensive intervention models for substance use disorders: A systematic review. Drug and Alcohol Review. 2018; 37 (S1): S246-S62.Google Scholar
Kelly, J. F., Bergman, B., Hoeppner, B. B., Vilsaint, C., White, W. L. Prevalence and pathways of recovery from drug and alcohol problems in the United States population: Implications for practice, research, and policy. Drug and Alcohol Dependence. 2017; 181: 162–9.Google Scholar
White, W. L. Recovery/Remission from Substance Use Disorders: An Analysis of Reported Outcomes in 415 Scientific Reports, 1868–2011. Philadelphia Department of Behavioral Health and Intellectual Disability Services and Great Lakes Addiction Technology Transfer Center, 2012.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×